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Editorial on the Research Topic:
Lectins and Their Ligands in Shaping Immune Responses
Lectins are glycan-binding proteins that are involved in numerous biological processes including
cell development, cell–cell interactions, signaling pathways, and the immune response. In
innate immunity, lectins often act as pattern recognition receptors (PRRs) and recognize
pathogen-associated molecular patterns (PAMPs), but also damage-associated molecular patterns
(DAMPs). Thus, lectins may contribute to a protective immune response, for instance during
infections, but they may also be involved in immune pathology, for instance during sterile
inflammation. Main classes of lectins in innate immunity include C-type lectin receptors (CLRs),
siglecs, and galectins. Due to the manifold functions of these different classes of lectins in anti-
microbial defense as well as immune homeostasis, lectin targeting is a promising strategy to shape
immune responses in the context of infections, autoimmunity, cancer, or vaccination.
This Research Topic provides original research and discussions focusing on aspects such as
ligand recognition by lectin receptors, induced signaling pathways, and lectin-mediated effector
functions during infections and inflammatory processes. It also addresses the identification and
characterization of novel lectin ligands and discusses how lectin targeting can be exploited to
stimulate or modulate immune responses. The contributions to this Research Topic provide
in-depth insights into current research on the impact of lectins/lectin ligands on immune responses.
The collection of 18 articles published in this Research Topic comprises original Research Articles,
Methods and Opinion Articles, as well as Comprehensive and Mini-Reviews.
NOVEL LINK BETWEEN DECTIN-2 AND LC3-ASSCOCIATED
PHAGOCYTOSIS OF MYCOBIOTA
It is well-known that the CLR Dectin-2 contributes to fungal recognition. Previous studies
have shown an involvement of the microtubule-associated protein light-chain 3 (LC3)-associated
phagocytosis (LAP) in host/fungi interactions. The study by Lamprinaki et al. describes a novel
link between Dectin-2 and LAP in the host response to commensal fungi. By using defined
knockout systems, the authors show a connection between Dectin-2 binding of commensal yeasts,
internalization, and signaling via association with LAP.
CLRS AS NOVEL MARKERS OF DC SUBSETS
Conventional dendritic cells (cDCs) in humans can be subdivided into two subsets, CD141+
DCs (cDC1) and CD1c+ DCs (cDC2). Heger et al. identify the CLR CLEC10A (also known
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as Macrophage galactose-type C-type lectin) as a specific marker
for human cDC2. CLEC10A targeting using a CLEC10A-specific
monoclonal antibody as well as a bivalent ligand resulted in a
rapid internalization into cDC2 and increased cytokine responses
upon TLR7/8 stimulation. This study highlights CLEC10A as a
candidate receptor for in vivo antigen-targeting approaches.
CLR TARGETING FOR ANTIGEN DELIVERY
AND IMMUNE STIMULATION
Targeting CLRs expressed by antigen-presenting cells is a
promising strategy to enhance immune responses and to increase
the efficacy of vaccines. Numerous studies have shown that the
CLR DC-SIGN serves as an attractive target for the delivery
of antigens into DCs; however, the mechanism of how DC-
SIGN affects cross-presentation of antigens has not yet been fully
elucidated. The study by Horrevorts et al. addresses the dynamics
of DC-SIGN-mediated internalization, antigen processing, and
cross-presentation and analyzes the impact of Toll-like receptor-
4 (TLR4) on these processes. The authors conclude that the
combined use of DC-SIGN and TLR4 ligands may serve as an
antigen-targeting platform to boost antigen cross-presentation to
CD8+ T cells.
Velasquez et al. use an antibody-mediated DC-SIGN
targeting approach to enhance CD4+ T cell responses against
mycobacterial antigens. Using the hSIGN mouse expressing
human DC-SIGN under control of the murine CD11c promotor,
they observed increased frequencies of antigen-specific IFN-
γ
+IL-2+TNF-α+ polyfunctional CD4+ T cells upon antigen
targeting to DC-SIGN. Using a similar targeting approach for
CD209a/SIGNR5 (mouse DC-SIGN), Schetters et al. show that
ovalbumin (OVA)-conjugated anti-SIGNR5 antibody elicited
robust antigen-specific CD4+ and CD8+ T cell responses
and enhanced OVA-specific antibody responses in vivo. These
findings highlight the utility of this CLR as a target for antigen
delivery and immune stimulation.
IDENTIFYING NOVEL CLR/BACTERIA
INTERACTIONS
In order to identify novel interactions of lectin receptors with
pathogens, appropriate research tools are needed. In their
Methods article, Mayer et al. describe applications of CLR-
Fc fusion proteins to screen for yet unknown CLR/bacteria
interactions. Using Campylobacter jejuni as an example, they
identify Dectin-1 as a candidate CLR in C. jejuni recognition
whose functional role can now be investigated in further studies.
ASSOCIATION OF C-TYPE LECTIN WITH
PULMONARY TUBERCULOSIS
CLRs have been implicated in the recognition of mycobacteria
and the induction of anti-mycobacterial immunity (see the
review article by Wagener et al. in this Research Topic).
Klassert et al. used an AmpliSeq-based approach to screen main
CLR gene clusters and CLR pathway-related genes for single
nucleotide polymorphisms (SNPs) associated with pulmonary
tuberculosis in an Indian population. One SNP in the
gene encoding for the Mannan-binding lectin serine protease
1 (MASP1) was found to be significantly associated with
pulmonary tuberculosis in this population, thus suggesting an
involvement of the lectin pathway of the complement system in
tuberculosis pathogenesis.
ROLE OF SIGLECS AND GALECTINS IN
IMMUNE MODULATION
While most of the articles included in this Research Topic deal
with CLRs, the two other main classes of lectins in innate
immunity, siglecs, and galectins, must not be underestimated.
Siglecs represent a lectin superfamily that is widely expressed by
immune cell subsets and characterized by binding to sialic acid
residues. The study by Nagala et al. investigates a potential role
of Siglec-E as a negative regulator of TLR4-mediated endocytosis
and signaling as proposed in previous studies. However,
while Siglec-E induction by bacterial lipopolysaccharide (LPS)
modulated the phenotype of macrophages, their study does
not support a significant role for Siglec-E in TLR4-mediated
endocytosis and signaling functions.
Galectins share a common structural fold and exhibit a
preference for N-acetyllactosamine-containing glycoconjugates.
In their Perspective article, Sundblad et al. discuss findings on
galectin functions in intestinal inflammation. Their data indicate
that galectins represent active players in the intestinal mucosa to
preserve immune and epithelial homeostasis. Thus, galectinsmay
serve as promising biomarkers and therapeutic targets during
severe mucosal inflammation.
CLRS IN INFECTION, INFLAMMATION,
AND AUTOIMMUNITY
The Research Topic is complemented by comprehensive
review and opinion articles focusing on the functions of
CLRs in infection, inflammation and autoimmunity. In their
review article, Goyal et al. describe CLR interaction with
human pathogenic fungi. The authors summarize known
functions of CLRs, such as Dectin-1, Dectin-2, Mincle, Mannose
receptor (MR), and DC-SIGN, in fungal recognition and
highlight their relevance in orchestrating antifungal responses.
Besides their role in antifungal immune responses, CLRs
are also involved in viral recognition. How CLRs contribute
to antiviral immunity on the one hand, but may also
be exploited by viruses to escape immune responses on
the other hand, is the focus of the review article by
Bermejo-Jambrina et al. The authors provide an overview
of known interactions between viruses and CLRs, including
the impact of CLR engagement on virus internalization,
transmission, and cross-presentation of viral antigens. In
addition, CLRs contribute to innate and adaptive immune
responses during viral infection, such as type-I interferon
responses or T helper cell polarization. Cross-talk mechanisms
between CLRs and complement receptors in opsonization
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and virus internalization are discussed in this review as
well. Wagener et al. review the relevance of the Dectin-
1/Syk/CARD9 signaling axis in anti-mycobacterial immunity.
The authors specify Dectin-1 functions in recognition of
mycobacteria and discuss recent findings on the crucial role
of Syk signaling and the adaptor protein CARD9 in anti-
mycobacterial immunity. While a distinct mycobacterial PAMP
recognized by Dectin-1 still remains to be identified, this
review highlights the relevance of the Dectin-1 pathway in
mounting an immune response to Mycobacterium tuberculosis,
which may lead to potential applications in tuberculosis vaccine
adjuvant development.
CLRs not only play an important role in the recognition
of pathogens, but may also sense DAMPs and contribute to
sterile inflammation and autoimmunity. Chiffoleau reviews this
essential role of CLRs as driving players of sterile inflammation
and highlights their relevance for autoimmune diseases, allergy,
or cancer. Specific aspects of how myeloid CLRs sense their
cognate ligands and crosstalk with heterologous receptors are
detailed by del Fresno et al. Their review article deals with the
diversity of signaling modules in CLRs. Signaling may require
CLR multimerization; the relative affinity or avidity of CLR
ligands may determine whether an activatory or inhibitory signal
is finally conveyed into the CLR-expressing cell. In conclusion,
further research is needed to understand how different signaling
pathways triggered by CLRs and heterologous receptors act
in concert.
Two articles in this Research Topic focus on CLRs in
autoimmune diseases. While Hadebe et al. review current
knowledge on the role of CLRs recognizing fungus-derived
and other allergens in asthma, the opinion article contributed
by te Velde discusses clues for a role of the CLR Mincle
in Crohn’s disease. The Research Topic is rounded by two
review articles on structural aspects of ligand recognition by
the CLR Mincle and the identification and characterization of
novel Mincle ligands. Williams discusses the structural basis of
Mincle recognition of lipidic ligands including sterols, glucose-
and glycerol-based glycolipids, and glycosyl diglycerides. This
review also details how variations of Mincle ligands have
provided insights into structure-activity relationships and may
help to identify novel Mincle ligands. Braganza et al. focus
on the chemical nature of known Mincle ligands and the
rational synthesis of analogs to screen for potent Mincle
agonists. Interestingly, subtle changes to functional groups in
the lipid backbone of Mincle ligands were found to markedly
affect their immune stimulatory properties. In conclusion,
Mincle agonists display promising potential as vaccine adjuvants
and immunotherapeutics.
CONCLUSIONS
Mounting evidence has demonstrated that lectin receptors play
crucial roles in innate immunity. This Research Topic provides
numerous examples of how lectins are involved in immune
responses during infections or inflammatory processes. It also
highlights the utility of lectin targeting for antigen delivery to
enhance vaccine efficacy. Future studies will unravel the potential
of lectins as therapeutic targets during infections, autoimmune
diseases, or cancer.
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